Surety Medicine

Last Updated: December 19, 2018
Man in hazmat suit

​Surety medicine focuses on protecting the health of the personnel who deal with nuclear, biological or chemical materials, and on medical requirements compliance to help ensure the security of the materials.

January 2019 Surety Medicine Teleconference:

IONIZING RADIATION DOSIMETRY AND THE NUCLEAR PRP:
INTERFACES BETWEEN THE HEALTH PHYSICIST AND THE CMA

Wednesday, 16 January 2019 will bring the first Surety Medicine Teleconference of the New Year, at 1 pm (1300 hrs) Eastern Time.  The topic for January is "Ionizing Radiation Dosimetry and the Nuclear Personnel Reliability Program:  Interfaces Between the Health Physicist and the Competent Medical Authority.”  The presenter will be a Health Physicist Supevisor for an Army Nuclear Personnel Reliability Program work site.
                              

To request additional information, email the Army Public Health Center Surety Medicine Division at:
usarmy.apg.medcom-aphc.mbx.surety-medicine@mail.mil.


    SCHEDULE OF UPCOMING SURETY MEDICINE TELECONFERENCES

(subject to change)
​16 JAN 2019Ionizing Radiation Dosimetry and the Nuclear PRP: Interfaces between the Health Physicist and CMA
20 FEB 2019​Cardiovascular Screening of Security Guards and Police:  PRP and IRP Considerations
​20 MAR 2019Diagnosis, Evaluation and Treatment of Laboratory-Acquired Botulinum Toxin Exposures
​17 APR 2019Bloodborne Pathogen Exposures:  Pre- and Post-Expsoure Prophylaxis 
​15 MAY 2019Substance Use Disorder Clinical Care (SUDCC) Intake Evaluations for PRP Candidates:  Suggested Approach
​19 JUN 2019Changing Most Probable Event Requirements in the Chemical Storage and Demilitarization  Environment
​17 JUL 2019The Dental Officer’s Perspective on Supporting the Personnel Reliability Program
21 AUG 2019​

Certifying Official, Behavioral Health Specialist, and CMA Interactions: PRP Case Studies

​18 SEP 2019

Urinary Metabolites, Protein Adducts and Bio-markers of Nerve and Vesicant Exposures

--ALERT--

Auto-Injector Shelf Life Extension Program: 

NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

Three production lots of atropine nerve agent antidote auto-injectors expired 31 January 2018, and additional lots expired in September 2018!   Check any auto-injector medication stores you have.  Select the link below for additional information.

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R)  combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to 2022.  Complete FDA information related to the auto-injector shelf life extension program can be found at this  FDA Drug Safety Page.

Information on this page also includes the latest updates (03/23/2018) on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors.